×
For best experience we recommend to activate Javascript in your browser.
TYSND1 antibody (C-Term)
This anti-TYSND1 antibody is a Rabbit Polyclonal antibody detecting TYSND1 in WB and ELISA. Suitable for Human.
Quick Overview for TYSND1 antibody (C-Term) (ABIN2380965)
Target
See all TYSND1 Antibodies
TYSND1
(Trypsin Domain Containing 1 (TYSND1))
Reactivity
All reactivities for TYSND1 antibodies
Human
Host
All hosts for TYSND1 antibodies
Rabbit
Clonality
All clonalities for TYSND1 antibodies
Polyclonal
Conjugate
All conjugates for TYSND1 antibodies
This TYSND1 antibody is un-conjugated
Application
All applications for TYSND1 antibodies
Western Blotting (WB), ELISA
Product Details anti-TYSND1 Antibody
(hide)
Binding Specificity
All epitopes for TYSND1 antibodies
AA 529-558, C-Term
Cross-Reactivity
Human, Mouse (Murine)
Cross-Reactivity (Details)
Calculated cross reactivity: Hu Mo
Characteristics
TYSND1, CT (TYSND1, Peroxisomal leader peptide-processing protease, Trypsin domain-containing protein 1, Peroxisomal leader peptide-processing protease, 15kD form, Peroxisomal leader peptide-processing protease, 45kD form)
Purification
Purified by Protein A affinity chromatography.
Immunogen
TYSND1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 529-558 amino acids from the C-terminal region of human TYSND1.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for TYSND1
(hide)
Target
TYSND1
(Trypsin Domain Containing 1 (TYSND1))
Alternative Name
TYSND1
NCBI Accession
NP_001035363 , NP_775826
UniProt
Q2T9J0
Pathways
SARS-CoV-2 Protein Interactome
Recently viewed
(hide)
Chat with us , powered by LiveChat